Patent · US Active

Compounds active towards nuclear receptors

US11780843B2 · kind B2 · utility

0Cited by
8References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 31, 2021
Grant dateOct 10, 2023
Priority date
Expiry dateOct 7, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.